TwinBeech Capital’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-253,795	Closed	-$3.9M	–	582
2024 Q3	$3.9M	Buy	+253,795	New	+$4.23M	0.07%	296
2024 Q2	–	Sell	-142,496	Closed	-$2.63M	–	498
2024 Q1	$2.63M	Buy	+142,496	New	+$3.53M	0.05%	303
2023 Q4	–	Sell	-316,555	Closed	-$6.6M	–	615
2023 Q3	$6.6M	Buy	316,555 +121,058	+62%	+$3.29M	0.13%	217
2023 Q2	$4.68M	Buy	195,497 +79,798	+69%	+$1.77M	0.09%	246
2023 Q1	$2.18M	Buy	+115,699	New	+$2.2M	0.04%	359
2022 Q3	–	Sell	-79,579	Closed	-$1.12M	–	591
2022 Q2	$1.12M	Buy	+79,579	New	+$1.49M	0.05%	307
2022 Q1	–	Sell	-21,366	Closed	-$499K	–	471
2021 Q4	$499K	Buy	+21,366	New	+$430K	0.03%	423
2021 Q2	–	Sell	-29,975	Closed	-$773K	–	424
2021 Q1	$773K	Buy	29,975 +25,941	+643%	+$1.14M	0.11%	229
2020 Q4	$216K	Sell	4,034 -14,253	-78%	-$708K	0.04%	403
2020 Q3	$754K	Buy	+18,287	New	+$790K	0.16%	192